Plus Therapeutics Inc: Ascendiant Capital Markets cuts target price from $22 to $21
Plus Therapeutics Inc：Ascendiant Capital Markets 将目标价格从22美元下调至21美元
Plus Therapeutics Inc: Ascendiant Capital Markets cuts target price from $22 to $21
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated